Victoria H Stiles1, Brad S Metcalf1, Karen M Knapp2, Alex V Rowlands3,4,5. 1. Sport and Health Sciences, College of Life and Environmental Sciences, University of Exeter, Exeter, UK. 2. University of Exeter Medical School, University of Exeter, Exeter, UK. 3. Diabetes Research Centre, University of Leicester, Leicester, UK. 4. National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, UK. 5. Alliance for Research in Exercise, Nutrition and Activity (ARENA), Sansom Institute for Health Research, Division of Health Sciences, University of South Australia, Adelaide, Australia.
Abstract
Background: Physical inactivity is a highly modifiable risk factor for the development of osteoporosis but, due to a lack of research that has precisely and objectively meaured physical activity (PA) relevant to bone, the specific contribution that PA can make to bone health is poorly understood. This study examined whether a more precise measure of PA relelvant to bone was associated with meaures of bone health in pre- and post-menopausal women in UK Biobank. Methods: Time spent at intensities specific to bone health [≥750 milli-gravitational units (mg) and ≥1000 mg] were analysed from raw tri-axial acceleration data averaged over 1-second epochs from 7-day monitoring of habitual PA using accelerometry-based activity monitors (100 Hz; AX3, Axivity, UK) of 1218 pre- and 1316 post-menopausal healthy women. In a cross-sectional analysis, associations between categories of time (<1, 1-2 and ≥2 minutes) spent above the intensity thresholds and calcaneal quantitative ultrasound measures of bone health (bone mineral density T-score, BMDT-score; speed of sound, SOS; and broadband ultrasound attenuation, BUA) were examined. Results: Compared with <1 minute, spending 1-2 or ≥2 minutes/day at intensities ≥1000 mg in pre-menopausal and ≥750 mg in post-menopausal women was positively associated with BMDT-score, SOS and BUA. Conclusion: Brief bursts of high-intensity PA relevant to bone health can be captured by applying bone-specific thresholds of intensity to raw tri-axial accelerations averaged over 1-second epochs. Accumulating 1-2 minutes/day of high-intensity PA, equivalent to running in pre-menopausal women and slow jogging in post-menopausal women, is associated with better bone health.
Background: Physical inactivity is a highly modifiable risk factor for the development of osteoporosis but, due to a lack of research that has precisely and objectively meaured physical activity (PA) relevant to bone, the specific contribution that PA can make to bone health is poorly understood. This study examined whether a more precise measure of PA relelvant to bone was associated with meaures of bone health in pre- and post-menopausal women in UK Biobank. Methods: Time spent at intensities specific to bone health [≥750 milli-gravitational units (mg) and ≥1000 mg] were analysed from raw tri-axial acceleration data averaged over 1-second epochs from 7-day monitoring of habitual PA using accelerometry-based activity monitors (100 Hz; AX3, Axivity, UK) of 1218 pre- and 1316 post-menopausal healthy women. In a cross-sectional analysis, associations between categories of time (<1, 1-2 and ≥2 minutes) spent above the intensity thresholds and calcaneal quantitative ultrasound measures of bone health (bone mineral density T-score, BMDT-score; speed of sound, SOS; and broadband ultrasound attenuation, BUA) were examined. Results: Compared with <1 minute, spending 1-2 or ≥2 minutes/day at intensities ≥1000 mg in pre-menopausal and ≥750 mg in post-menopausal women was positively associated with BMDT-score, SOS and BUA. Conclusion: Brief bursts of high-intensity PA relevant to bone health can be captured by applying bone-specific thresholds of intensity to raw tri-axial accelerations averaged over 1-second epochs. Accumulating 1-2 minutes/day of high-intensity PA, equivalent to running in pre-menopausal women and slow jogging in post-menopausal women, is associated with better bone health.
Authors: Charles E Matthews; Kong Y Chen; Patty S Freedson; Maciej S Buchowski; Bettina M Beech; Russell R Pate; Richard P Troiano Journal: Am J Epidemiol Date: 2008-02-25 Impact factor: 4.897
Authors: Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson Journal: J Bone Miner Res Date: 2007-03 Impact factor: 6.741
Authors: C M Weaver; C M Gordon; K F Janz; H J Kalkwarf; J M Lappe; R Lewis; M O'Karma; T C Wallace; B S Zemel Journal: Osteoporos Int Date: 2016-02-08 Impact factor: 4.507
Authors: Carol Ewing Garber; Bryan Blissmer; Michael R Deschenes; Barry A Franklin; Michael J Lamonte; I-Min Lee; David C Nieman; David P Swain Journal: Med Sci Sports Exerc Date: 2011-07 Impact factor: 5.411
Authors: K Hannam; K C Deere; A Hartley; E M Clark; J Coulson; A Ireland; C Moss; M H Edwards; E Dennison; T Gaysin; R Cooper; A Wong; J S McPhee; C Cooper; D Kuh; J H Tobias Journal: Osteoporos Int Date: 2016-10-31 Impact factor: 4.507
Authors: Vincent T van Hees; Lukas Gorzelniak; Emmanuel Carlos Dean León; Martin Eder; Marcelo Pias; Salman Taherian; Ulf Ekelund; Frida Renström; Paul W Franks; Alexander Horsch; Søren Brage Journal: PLoS One Date: 2013-04-23 Impact factor: 3.240
Authors: Victoria H Stiles; Matthew Pearce; Isabel S Moore; Joss Langford; Alex V Rowlands Journal: Med Sci Sports Exerc Date: 2018-11 Impact factor: 5.411
Authors: Yogini V Chudasama; Kamlesh K Khunti; Francesco Zaccardi; Alex V Rowlands; Thomas Yates; Clare L Gillies; Melanie J Davies; Nafeesa N Dhalwani Journal: BMC Med Date: 2019-06-12 Impact factor: 8.775
Authors: Joseph Henson; Alex V Rowlands; Emma Baldry; Emer M Brady; Melanie J Davies; Charlotte L Edwardson; Thomas Yates; Andrew P Hall Journal: BMJ Open Diabetes Res Care Date: 2020-07
Authors: Lisa N Zaidell; Ross D Pollock; Darren C James; Joanna L Bowtell; Di J Newham; David P Sumners; Katya N Mileva Journal: Dose Response Date: 2019-01-06 Impact factor: 2.658
Authors: X Li; Y Qiao; C Yu; Y Guo; Z Bian; L Yang; Y Chen; S Yan; X Xie; D Huang; J Chen; Z Chen; J Lv; L Li Journal: Osteoporos Int Date: 2018-11-15 Impact factor: 4.507